Japan Questions Reliability of Vasculitis Drug Approval Data
Tokyo, Oct. 21 (Jiji Press)--Japan's health ministry said Wednesday that there may be problems with the reliability of documents submitted by Kissei Pharmaceutical Co. for the approval of vasculitis drug Tavneos. In its response to a series of deaths among Tavneos users, the ministry reiterated its request that medical institutions refrain from starting new patients on the drug, which is ma...
We haven't written up this one. Nippon.com News has the full story — the link below goes straight to it.
